https://www.marketscreener.com/quote/stock/LYTIX-BIOPHARMA-123687662/news/Lytix-Biopharma-s-Licensing-Partner-Verrica-Pharmaceuticals-Inc-Reports-Interim-Phase-2-Data-with-L-44589282/?utm_source=telegram&utm_medium=social&utm_campaign=share